(Q30451645)

21 June 2017

title

The significance of tumor involved adenomyosis in otherwise low-stage endometrioid adenocarcinoma (English)

1 reference

21 June 2017

The Significance of Tumor Involved Adenomyosis in Otherwise Low-stage Endometrioid Adenocarcinoma (English)

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

22 June 2024

1 reference

Krisztina Z. Hanley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736770

22 June 2024

Simone M. Dustin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736770

22 June 2024

Mark H. Stoler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736770

22 June 2024

Kristen A. Atkins

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736770

22 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20736770

22 June 2024

publication date

1 September 2010

1 reference

full work available at URL

21 June 2017

http://journals.lww.com/00004347-201009000-00009

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

International Journal of Gynecological Pathology

22 June 2024

published in

1 reference

21 June 2017

volume

29

1 reference

21 June 2017

issue

5

1 reference

21 June 2017

page(s)

445-451

1 reference

21 June 2017

cites work

Cancer statistics, 2006

1

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects

22 June 2024

2

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

22 June 2024

Endometrial carcinoma

3

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus

22 June 2024

4

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

Pathologic models to predict outcome for women with endometrial adenocarcinoma: the importance of the distinction between surgical stage and clinical stage--a Gynecologic Oncology Group study

22 June 2024

5

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma

22 June 2024

6

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

Prevalence and risk factors of adenomyosis at hysterectomy

22 June 2024

7

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

Pathophysiology of adenomyosis.

22 June 2024

8

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

The prognostic significance of adenomyosis in endometrial carcinoma

22 June 2024

10

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

Endometrial adenocarcinoma arising in adenomyosis

22 June 2024

11

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis

22 June 2024

12

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis

22 June 2024

13

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases

22 June 2024

14

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis

22 June 2024

15

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

The ability to evaluate prognostic variables on frozen section in hysterectomies performed for endometrial carcinoma.

22 June 2024

16

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma.

22 June 2024

19

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

An analysis of the impact of pathology review in gynecologic cancer

22 June 2024

20

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion

22 June 2024

21

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma

22 June 2024

22

1 reference

https://api.crossref.org/works/10.1097/PGP.0B013E3181D81DE6

22 June 2024

Identifiers

1 reference

21 June 2017

1 reference